Cargando…
Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation
The portal venous circulation provides a conduit for pancreatic ductal adenocarcinoma (PDAC) tumor cells to the liver parenchyma sinusoids, a frequent site of metastasis. Turbulent flow in the portal circulation promotes retention of PDAC shed circulating tumor cells (CTC) and myeloid-derived immuno...
Autores principales: | Arnoletti, Juan Pablo, Reza, Joseph, Rosales, Armando, Monreal, Alberto, Fanaian, Na’im, Whisner, Suzanne, Srivastava, Milan, Rivera-Otero, Julia, Yu, Gongxin, Phanstiel IV, Otto, Altomare, Deborah A., Tran, Quang, Litherland, Sally A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939813/ https://www.ncbi.nlm.nih.gov/pubmed/35316296 http://dx.doi.org/10.1371/journal.pone.0265725 |
Ejemplares similares
-
K-RAS Mutant Gene Found in Pancreatic Juice
Activated Chromatin From Peri-ampullary Adenocarcinomas
por: Reza, Joseph, et al.
Publicado: (2019) -
Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
por: Freed, Ian M., et al.
Publicado: (2023) -
Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells
por: Gitto, Sarah B., et al.
Publicado: (2020) -
Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood
por: Cox, Amanda, et al.
Publicado: (2022) -
The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
por: Kumar, Swati, et al.
Publicado: (2022)